Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
CazYCNJydmBxfeCR